Fosinopril Sodium (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Fosinopril Sodium drug offered from Aurobindo Pharma Limited. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
| NON-PROPRIETARY NAME: | Fosinopril Sodium |
| SUBSTANCE NAME: | FOSINOPRIL SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-03-30 |
| END MARKETING DATE: | 0000-00-00 |
Fosinopril Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fosinopril Sodium from Aurobindo Pharma Limited |
| LABELER NAME: | Aurobindo Pharma Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2011-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65862-471_b1c86ca7-9169-43a3-b167-214bb5306f29 |
| PRODUCT NDC: | 65862-471 |
| APPLICATION NUMBER: | ANDA091163 |
Other FOSINOPRIL SODIUM Pharmaceutical Manufacturers / Labelers:
